Pages that link to "Q35176984"
Jump to navigation
Jump to search
The following pages link to Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. (Q35176984):
Displaying 50 items.
- Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide (Q21195191) (← links)
- Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer (Q21195199) (← links)
- Pioneer transcription factors: establishing competence for gene expression (Q24625373) (← links)
- Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer (Q26765380) (← links)
- Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation (Q26770051) (← links)
- Cooperating transcription factors mediate the function of estrogen receptor (Q26996464) (← links)
- Androgen Receptor: A Complex Therapeutic Target for Breast Cancer (Q28075188) (← links)
- Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation (Q28244711) (← links)
- A secretory cell type develops alongside multiciliated cells, ionocytes and goblet cells, and provides a protective, anti-infective function in the frog embryonic mucociliary epidermis (Q28657650) (← links)
- The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set. (Q30978083) (← links)
- Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling. (Q33612132) (← links)
- Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype (Q33733903) (← links)
- Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer (Q33915040) (← links)
- Interrogating genomic and epigenomic data to understand prostate cancer (Q34125866) (← links)
- Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations (Q34309894) (← links)
- FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast. (Q34497523) (← links)
- Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis (Q34547261) (← links)
- Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. (Q34714945) (← links)
- Coagulation factor VII is regulated by androgen receptor in breast cancer (Q34995790) (← links)
- TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer (Q35074030) (← links)
- FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer (Q35089958) (← links)
- FOXA1: master of steroid receptor function in cancer (Q35532767) (← links)
- Multiscale Embedded Gene Co-expression Network Analysis (Q35855670) (← links)
- New insights into the role of androgen and oestrogen receptors in molecular apocrine breast tumours (Q35889554) (← links)
- Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo (Q35946392) (← links)
- Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer (Q35949760) (← links)
- FOXA1 represses the molecular phenotype of basal breast cancer cells (Q36020557) (← links)
- Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer (Q36030567) (← links)
- Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? (Q36113793) (← links)
- The Role of Androgen Receptor in Breast Cancer. (Q36275556) (← links)
- Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer (Q36356432) (← links)
- Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells (Q36367151) (← links)
- The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation (Q36393201) (← links)
- Regulators of genetic risk of breast cancer identified by integrative network analysis (Q36419747) (← links)
- Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells (Q36509058) (← links)
- KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1 (Q36544671) (← links)
- Expression of androgen receptor splice variants in clinical breast cancers. (Q36689084) (← links)
- Amplitude modulation of androgen signaling by c-MYC. (Q36804105) (← links)
- Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target (Q36849142) (← links)
- Pan-cancer analyses of the nuclear receptor superfamily (Q36907762) (← links)
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer (Q36908403) (← links)
- Molecular pathogenesis and progression of prostate cancer (Q37055715) (← links)
- A functional link between FOXA1 and breast cancer SNPs (Q37100413) (← links)
- Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (Q37367871) (← links)
- Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status (Q37520209) (← links)
- Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. (Q37528787) (← links)
- Role of the androgen receptor in triple-negative breast cancer (Q37573317) (← links)
- Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer (Q37629540) (← links)
- AR-Signaling in Human Malignancies: Prostate Cancer and Beyond (Q37629545) (← links)
- AR Signaling in Breast Cancer (Q37721492) (← links)